American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 11 | 2 | 5 | 10 |
| Receivables | 2 | 3 | 3 | 20 | N/A |
| Inventories | 23 | 23 | 20 | 0 | 23 |
| Other current assets | 0 | 0 | 65 | 5 | 1 |
| TOTAL | $25 | $37 | $90 | $30 | $34 |
| Non-Current Assets | |||||
| PPE Net | 24 | 26 | 30 | 30 | 26 |
| Other Non-Current Assets | 1 | 1 | 1 | 6 | 0 |
| TOTAL | $25 | $26 | $31 | $36 | $26 |
| Total Assets | $50 | $63 | $110 | $60 | $60 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 212 | 183 | 180 | 240 | 229 |
| Accrued Expenses | 105 | 73 | 60 | 30 | N/A |
| TOTAL | $397 | $332 | $290 | $570 | $457 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 275 | 246 | 210 | 180 | 158 |
| TOTAL | $275 | $246 | $210 | $180 | $158 |
| Total Liabilities | $672 | $578 | $500 | $760 | $615 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32 | N/A | N/A | N/A | N/A |
| Common Shares | 32 | 32 | 30 | 30 | 31 |
| Retained earnings | -1,943 | -1,836 | -1,710 | -1,850 | -1,705 |
| Other shareholders' equity | 0 | 0 | 10 | 10 | 0 |
| TOTAL | $-622 | $-515 | $-390 | $-700 | $-555 |
| Total Liabilities And Equity | $50 | $63 | $110 | $60 | $60 |